ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: The breakpoint cluster region-Abelson (BCR-ABL), a fusion oncoprotein with tyrosine kinase activity, is frequently detected in patients with chronic myeloid leukemia (CML).